TABLE 4
Comparison of SUVmax in Malignant Lesions With and Without ADT
Parameter
Ongoing ADT
No ADT
P
Local recurrence
6.6 ± 2.8
5.9 ± 2.0
0.41
LN metastases
5.1 ± 2.5
7.1 ± 3.4
0.24
Bone metastases
13.4 ± 7.8
5.9 ± 2.3
0.15